Damaschin C, Goergen H, Kreissl S, Plutschow A, et al. Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group. Leukemia 2021 Aug 18. pii: 10.1038/s41375-021-01386.
PMID: 34408266